Cystatin C Provides more information than other renal function parameters for stratifying risk in patients with acute coronary syndrome;La cistatina C aporta más información que otros parámetros de función renal en la estratificación del riesgo de los pacientes con síndrome coronario agudo

Revista Espanola de Cardiologia

Volumn 62, Issue 5, 2009, Pages 510-519

  García Acuña, José M ^a   González Babarro, Eva ^a   Grigorian Shamagian, Lilian ^a   Peña Gil, Carlos ^a   Vidal Pérez, Rafael ^a   López Lago, Ana M ^a   Gutiérrez Feijoó, Mario ^a   González Juanatey, José R ^a  

^a Unidad Coronaria   (Spain)

Author keywords

Acute coronary syndrome; C reactive protein; Cistatina C; Cystatin C; Heart failure; Insuficiencia cardiaca; Prote na C reactiva; S ndrome coronario agudo

Indexed keywords

C REACTIVE PROTEIN; CHOLESTEROL; CREATININE; CYSTATIN C; TROPONIN I; BIOLOGICAL MARKER;

ACUTE CORONARY SYNDROME; ADULT; AGE; AGED; ARTICLE; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HEART EJECTION FRACTION; HEART FAILURE; HEART MUSCLE NECROSIS; HUMAN; KAPLAN MEIER METHOD; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MORTALITY; PROGNOSIS; PROSPECTIVE STUDY; RISK ASSESSMENT; STATISTICAL ANALYSIS; BLOOD; KIDNEY FUNCTION TEST; MIDDLE AGED;

ACUTE CORONARY SYNDROME; AGED; BIOLOGICAL MARKERS; CYSTATIN C; FEMALE; FOLLOW-UP STUDIES; GLOMERULAR FILTRATION RATE; HUMANS; KAPLAN-MEIERS ESTIMATE; KIDNEY FUNCTION TESTS; MALE; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDIES; RISK ASSESSMENT;

EID: 68049123420     PISSN: 03008932     EISSN: 15792242     Source Type: Journal    
DOI: 10.1016/S0300-8932(09)71031-0     Document Type: Article

References (32)

1. R. Carda, J.A. De Agustín, M.C. Manzano, J.C. García- Rubira, A. Fernández-Ortiz, and I. Vilacosta Valor pronóstico intrahospitalario del filtrado glomerular en pacientes con síndrome coronario agudo y creatinina normal Rev Esp Cardiol 60 2007 714 719
2. M.G. Shlipak, J.A. Simon, D. Grady, F. Lin, N.K. Wenger, and C.D. Furger Renal insufficiency and cardiovascular events in postmenopausal women with coronary heart disease J Am Coll Cardiol 38 2001 705 711
3. D.W. Cockcroft, and M.H. Gault Prediction of cretinine clearance from serum creatinine Nephron 16 1976 31 41
4. A.S. Levey, J.P. Bosch, J.B. Lewis, T. Greene, N. Rogers, and D. Roth A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation Ann Intern Med 130 1999 461 470
5. L.A. Stevens, J. Coresh, T. Greene, and A.S. Levey Assesing kidney function - measured and estimated glomerular filtration rate N Engl J Med 354 2006 2473 2483
6. M.G. Shlipak, R. Katz, M.J. Sarnak, L.M. Fried, A.B. Newman, and C. Stehman-Breen Cystatin C and prognosis for cardiovascular and kidney outcomes in elderly persons without chronic kidney disease Ann Intern Med 145 2006 237 246
7. D. Singh, M.A. Whooley, J.H. Ix, S. Ali, and M.G. Shlipak Association of cystatin C and estimated GFR with inflammatory biomarkers: the Heart and Soul Study Nephrol Dial Transplant 22 2007 1087 1092 (Pubitemid 46523422)
8. A.G. Christensson, A.O. Grubb, J.A. Nilsson, K. Norrgren, G. Sterner, and G. Sundkvist Serum cystatin C advantageous compared with serum cretatinine in the detection of mild but no severe diabetic nephropathy J Inter Med 256 2004 510 518
9. M.G. Shlipak, M.J. Sarnak, R. Katz, L.F. Fried, S.L. Seliger, and A.B. Newman Cystatin C and the risk of death and cardiovascular events among elderly persons N Eng J Med 352 2005 2049 2060
10. L. Fácila, J. Núñez, V. Bodí, J. Sanchos, V. Bertomeu-González, and L. Consuegra Valor pronóstico de la creatinina sérica en el síndrome coronario agudo sin elevación del segmento ST Rev Esp Cardiol 59 2006 209 216 (Pubitemid 43674946)
11. M. Gibson, D. Pinto, S. Murphy, D.A. Morrow, H.-P. Hobbach, and S.D. Wiviott Association of creatinine and creatinine clearance on presentation in acute myocardial infarction with subsequent mortality J Am Coll Cardiol 42 2003 1535 1543
12. L. Grigorian, A. Varela, M. Pedreira, I. Gómez, A. Virgós, and J.R. González-Juanatey La insuficiencia renal es un predictor independiente de la mortalidad en pacientes hospitalizados por insuficiencia cardiaca y se asocia con un peor perfil de riesgo cardiovascular Rev Esp Cardiol 59 2006 99 108
13. C. Mueller, F.-J. Neumann, A. Perruchoud, and H.J. Buettner Renal function and long term mortality after unstable angina/non-ST segment elevation myocardial infarction treated very early an d predominatly with percutaneous coronary intervention Heart 90 2004 902 907
14. S. Wison, K. Foo, J. Cunningham, J. Cooper, A. Deaner, and C. Knight Renal function and risk stratification in acute coronary syndromes Am J Cardiol 91 2003 1051 1054
15. D.E. Wiener, H. Tighiouart, and M.G. Amin Chronic kidney disease as a risk factor for cardiovascular disease and all-cause mortality: a pooled analysis of community-based studies J Am Soc Nephrol 15 2004 1307 1315
16. A. Verma, N.S. Anavekar, A. Meris, J.J. Thune, J.M. Arnold, and J.K. Ghali The relationship between renal function and cardiac structure, function, and prognosis after myocardial infarction: the VALIANT Echo Study J Am Coll Cardiol 50 2007 1238 1245
17. P. Jose, H. Skali, N. Anavekar, C. Tomson, H.M. Krumholz, and J.L. Rouleau Increase in creatinine and cardiovascular risk in patients with systolic dysfunction after myocardial infarction J Am Soc Nephrol 17 2006 2886 2891
18. H.C. Gerstein, J. Bosch, J. Pogue, D.W. Taylor, B. Zinman, and S. Yusuf Rationale and design of a large study to evaluate the renal and cardiovascular effects of an ACE inhibitor and vitamin E in high-risk patients with diabetes. The MICRO-HOPE Study. Microalbuminuria, cardiovascular, and renal outcomes. Heart Outcomes Prevention Evaluation Diabetes Care 9 1996 1225 1228
19. S.D. Solomon, M.M. Rice, K. Jablonski, P. Jose, M. Domanski, and M. Sabatine Renal function and effectiveness of angiotensinconverting enzyme inhibitor therapy in patients with chronic stable coronary disease in the Prevention of Events with ACE inhibition (PEACE) trial Circulation 114 2006 26 31
20. M.P. Tokmakova, H. Skali, S. Kenchaiah, E. Braunwald, J.L. Rouleau, and M. Packer Chronic kidney disease, cardiovascular risk, and response to angiotensin-converting enzyme inhibition after myocardial infarction Circulation 110 2004 3667 3673
21. W. Schiffrin, M.L. Lipman, and J.F. Mann Chronic kidney disease effects on the cardiovascular system Circulation 116 2007 85 97
22. J.J. Brugts, E. Boersma, M. Chonchol, J.W. Deckers, M. Bertrand, and W.J. Remme The cardioprotective effects of the angiotensin-converting enzyme inhibitor perindopril in patients with stable coronary artery disease are not modified by mild to moderate renal insufficiency: insights from the EUROPA trial J Am Coll Cardiol 50 2007 2148 2155
23. R.S. Gardner, K.S. Chong, E. O'Meara, A. Jardine, I. Ford, and T.A. McDonagh Renal dysfunction, as measure by modification of diet in renal disease equations, and outcome with advance heart failure Eur Heart J 28 2007 3027 3033
24. J.H. Ix, M.G. Shlipak, G.M. Chertow, and M.A. Whooley Association of Cystatin C with mortality, cardiovascular events, and incident heart failure among persons with coronary heart disease: data from the Heart and Soul study Circulation 115 2007 173 179
25. W. Koenig, D. Twardella, H. Brenner, and D. Rothenbacher Plasma concentrations of cystatin C in patients with coronary heart disease and risk for secondary cardiovascular events: more than simply a marker of glomerular filtration rate Clin Chem 51 2005 321 327 (Pubitemid 40175801)
26. T. Jernberg, B. Lindahl, S. James, A. Larsson, L.O. Hansson, and L. Wallentin Cystatin C: a novel predictor of outcome in suspected or confirmed non-ST- elevation acute coronary syndrome Circulation 110 2004 2342 2348
27. J.C.S. Chew, M. Saleem, C. Florkowski, and P.M. George Cystatin C. A paradigm of evidence based laboratory medicine Clin Biochem Rev 29 2008 47 62
28. P.L. Sánchez, M.V. Rodríguez, E. Villacorta, C. Albarrán, I. Cruz, and J.M. Moreiras Cinética de la proteína C reactiva en las distintas manifestaciones clínicas del síndrome coronario agudo Rev Esp Cardiol 59 2006 441 447
29. I. Ferreira-González, C. Permayer-Miralda, J. Marrugat, M. Heras, J. Cuñat, and E. Civeira Estudio MASCARA (Manejo del Síndrome Coronario Agudo. Registro Actualizado). Resultados globales Rev Esp Cardiol 61 2008 803 816
30. M. Loew, M.M. Hoffmann, W. Koenig, H. Brenner, and D. Rothenbacher Genotype and plasma concentration of cystatin C in patients with coronary heart disease and risk for secondary cardiovascular events Arterioscler Thromb Vasc Biol 25 2005 1470 1474
31. G. Luc, J.M. Bard, C. Lesueur, D. Arveiler, A. Evans, and P. Amouyel Plasma cystatin-C and development or coronary heart disease: the PRIME study Atherosclerosis 185 2006 375 380
32. A. Levin Cystatin C, serum creatinine and estimates of kidney function: searching for better measures of kidney function and cardiovascular risk Ann Intern Med 142 2005 586 588